MedPath

Microwave Ablation of Resectable Liver Tumors

Withdrawn
Conditions
Hepatocellular Carcinoma
Liver Cancer
Registration Number
NCT00892255
Lead Sponsor
St. Joseph Hospital of Orange
Brief Summary

The purpose of this protocol is to pathologically evaluate the destruction by microwave ablation of primary and metastatic liver tumors. The primary aim is to measure tissue destruction with the MedWaves Microwave Ablation/ Coagulation Ablation System.

Detailed Description

Minimally invasive surgical alternatives are becoming more attractive for the treatment of malignancy.The goal is to reduce morbidity and mortality and increase the ability to treat patients in the outpatient setting. Image-guided ablation is becoming an attractive alternative because of its relative low cost, its ability to provide large regions of coagulative necrosis in a controlled fashion, and its relatively low toxicity. Although image-guided ablative techniques have been extensively investigated for the treatment of liver tumors, there has been limited experience with microwave ablation (MWA) in the liver. This study will evaluate the treatment effect of MWA in liver tumors. Patients undergoing planned surgical removal of liver tumors will have the tumors intra-operatively treated with MWA. The histological changes will be evaluated upon removal of the specimen.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Diagnosis of primary or metastatic liver cancer for which surgery is planned
  • All participants need to be fully able to give informed consent
Exclusion Criteria
  • Mental or legal incompetence
  • Impaired decision-making capacity
  • Pregnant women may not participate

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Measure of the tissue destruction with the MedWaves Microwave Ablation/ Coagulation Ablation System30 Days

Measure of the tissue destruction with the MedWaves Microwave Ablation/ Coagulation

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

The Center for Cancer Prevention & Treatment at St. Joseph Hospital

🇺🇸

Orange, California, United States

© Copyright 2025. All Rights Reserved by MedPath